Amorphous Solid Dispersions

Part I: Introduction and Fundamentals.- Chapter 1: Introduction to Amorphous Solid Dispersions.- Chapter 2: Physical Stability of Amorphous Drugs and Amorphous Solid Dispersions.- Chapter 3: Polymer Selection for the Successful Preparation of Amorphous Solid Dispersions.- Part II: Manufacturing and Engineering Technologies.- Chapter 4: Hot Melt Extrusion (HME) as an Innovative Technology for the Design and Development of Amorphous Solid Dispersions.- Chapter 5: Solvent Evaporation Approaches for the Preparation of Amorphous Solid Dispersions.- Chapter 6: Mechanochemical Approaches for the Preparation of Amorphous Solid Dispersions.- Part IIΙ: Emerging and Alternative ASD Platforms.- Chapter 7: Evolving Perspectives on Co-Amorphous Drug Delivery Systems: From Fundamentals to Recent Advancements (2021–2025).- Chapter 8: High Drug Loading Amorphous Solid Dispersions.- Part IV: Downstream Processing and Patient-Centric Design.- Chapter 9: Downstream Processing of Amorphous Solid Dispersions of Drugs.- Chapter 10: Improving Paediatric Drug Delivery through Amorphous Solid Dispersions (ASD).- Part V: Biopharmaceutical Evaluation and Translation.- Chapter 11: Assessing the In Vivo Performance of Orally Administered Amorphous Drug Solid Dispersions in Healthy Adults from In Vitro Data.- Chapter 12: Regulatory Aspects and Commercialization of Drug Products Containing Amorphous Solid Dispersions.- Chapter 13: Future Perspectives: Artificial Intelligence, Continuous Manufacturing, and Personalized ASDs.